Abstract: Studies suggest a relationship of manic behavior and bipolar disorder (BD) with behavioral variant frontotemporal dementia (bvFTD). The nature of this relationship is unclear. This report presents a patient with initial manic behavior as the main manifestation of familial bvFTD from a novel progranulin (GRN) mutation. In contrast, there are other reports of a long background of BD preceding a diagnosis of bvFTD. A review of the literature and this patient suggest that manic symptoms result from damage to right frontotemporal neural structures from longstanding BD, as well as from bvFTD and other focal neurological disorders. In addition, there is a subgroup of patients with a probable genetic predisposition to both BD and bvFTD.
Introduction
Behavioral variant frontotemporal dementia (bvFTD) is a neurodegenerative disorder that can present with subtle alterations of personality. 1 The onset is usually insidious in mid-life, with progression to severe dementia caused by atrophy of the frontal and anterior temporal lobes. Most commonly, patients develop apathy or abulia, disinhibition or impulsivity, loss of sympathy or empathy, compulsions and stereotypies, and dietary changes, particularly carbohydrate cravings. 1 Many, if not most, patients with bvFTD present to psychiatrists and other mental health specialists with concerns over depression, anxiety, mid-life crisis, and other conditions, before a neurodegenerative brain disorder is considered. 2 The early diagnosis and management of bvFTD depends on recognizing the range of initial and presenting signs and symptoms of this disorder. This report presents a familial bvFTD patient who initially developed manic symptoms, and reviews the literature on the relationship of bipolar symptoms and bvFTD. Written informed consent was provided by the patient's husband, who is the legal guardian for this case report and any accompanying images.
Case report
A 63-year-old right-handed woman with 16 years of education had a 2-year history of personality change, characterized as becoming increasing rude in conversation. Her husband reported that she would constantly interrupt and talk out of turn, speaking rapidly about topics tangential to the conversation. Her thoughts and speech would then go from one unrelated topic to another. This change was the husband's main complaint, with an immediate precipitating event being the exclusion from her social group at her country club. Her husband described her as having an "acquired attention deficit hyperactivity behavior", with decreased attention span and concentration, hyperactivity and fidgetiness, and restless inability to sit still for any prolonged period of time. He further described her as having diminished empathy or responsiveness to others' feelings, and impulsive or inappropriate behavior, such as making offensive remarks and uncharacteristic arguments with peers. He observed her having difficulties with organization, multitasking, and following a sequence of steps to complete a task, such as cooking a meal. She was mostly independent in her routine and instrumental activities of daily living. The patient herself stated: "I am not aware of any changes. I just need to keep walking. I cannot sit still". The review of psychiatric and neurological systems was negative for decreased need for sleep, increased goal-directed activity, risky behavior, compulsive-like acts, or dietary changes. Her past medical history was otherwise negative, but her family history was positive for an affected brother with an unknown "dementia" at age 68 and early dementia in her mother's family (her mother died relatively young of colon cancer).
On examination, she appeared restless, constantly moving, and hyperactive. Her speech was intrusive with tangential verbal output. She would quickly lapse into a totally unrelated story, going rapidly from one topic to another, appearing derailed by any transient idea or thought. Much of her rapid speech was imperfectly spoken with omitted words. Her mood and affect appeared euthymic, and there was no evidence of an expansive or euphoric mood, grandiosity, or inflated self-esteem. There was no evidence of a formal thought disorder or psychotic features.
On her neurocognitive assessment, she was oriented in all spheres and had 26/30 on the Mini-Mental State Examination, 3 missing memory items and the intersecting pentagons. When asked to slow down, however, she could do a good drawing, despite tending to rush through the tasks. Attention testing showed a digit span of 5 forward, but only 1 in reverse, and she was quickly derailed on any vigilance test. Her language was fluent, with normal comprehension, repetition, and confrontational naming, and she had word lists of 12 animals/min and nine "F" words/min. On an auditory verbal learning test, she recalled 7/10 words at 15 min, with recognition of 10/10. Her remote memory and knowledge of current events were intact. On visuospatial testing, she had disproportionate difficulty with faces, recognizing only 14 of 26 famous faces. Single-digit and double-digit addition and multiplication were normal, and there was no limb apraxia. The patient gave concrete interpretations to proverbs such as "people in glass houses shouldn't throw stones" (eg, "the glass would break"). On the Frontal Assessment Battery, 4 she scored 15/18; the patient was able to complete alternating tapping, and the GoNoGo test, but got only two of six trials on the Luria alternating hand sequences. She was normal on the rest of the neurological examination, including cranial nerves, gait and coordination, motor, sensation, and reflexes. The patient underwent a series of diagnostic tests. Routine blood laboratory tests were normal. Neuropsychological assessment showed predominant evidence of decreased executive functions in processing speed, mental shifting, auditory working memory, and the ability to efficiently shift cognitive set. Performance on these executive tests was generally ,1st percentile compared to tests of language (48th for animal list verbal fluency), visuospatial abilities (5th for block design), and memory (69th for long delay free recall). Her magnetic resonance imaging (MRI) and fluorodeoxyglucose positron emission tomography (PET) imaging showed asymmetric, predominant right frontotemporal degeneration and hypometabolism, although there was significant involvement of the left temporal lobe as well right parietal hypometabolism on PET (see Figure 1) .
The patient was diagnosed with right frontotemporal predominant bvFTD, based on a progressive deterioration of behavior with early disinhibition and social impropriety, diminished empathy, predominant executive neuropsychological deficits, and supportive neuroimaging. Genetic testing for the major FTD genes revealed a novel progranulin nonsense mutation (c.6 G.A; p.Trp2X). The patient subsequently progressed, developing other features of bvFTD such as carbohydrate craving and compulsive-like behaviors, which partially responded to sertraline at doses up to 200 mg/day.
Discussion
This patient presented with manic behavior, and proved to have a predominant right frontotemporal variant of bvFTD. She had press of speech, flight of ideas, distractibility to irrelevant external stimuli, and psychomotor agitation. She did not have other manic symptoms, such as a truly elevated mood with inflated self-esteem or grandiosity, decreased need for sleep, or increased goal-directed or risky behaviors; hence, she did not fulfill all criteria for mania. 5 She was tangential in her conversation, and showed "derailment", a process where she would go off on her own with loosely related or totally unrelated commentary. Finally, neuroimaging revealed predominant right frontotemporal involvement, with relative sparing of the left frontal lobe.
This patient has a novel mutation in the progranulin (GRN) gene on chromosome 17. GRN mutations make up 5%-10% of known familial frontotemporal degenerations, compared to 
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Mania-like behavior in bvFTD 12% from chromosome 9 open frame reduction 72 (C9orf72) and 2%-11% from microtubular-associated protein tau (MAPT) mutations. 6 This patient's GRN mutation (c.6 G.A; p.Trp2X) adds to the approximate 172 known GRN mutations (http://www.molgen.ua.ac.be/). GRN mutations are autosomal dominant, with about 95% having an affected parent, 6 which is not reported in this patient, probably because of her mother's early death from cancer. The GRN gene encodes for progranulin, a precursor protein that is eventually cleaved into granulins, which regulate cell growth and participate in wound healing and tumorigenesis. GRN mutations result in haploinsufficiency, with a decrease in granulin production. 
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Patients with GRN mutations have an average age of onset of 62 years, but age of onset can range from 35 to 87 years, with a disease duration of 3-12 years. 6 They most commonly present with behavioral disorders consistent with bvFTD, but can also present with nonfluent variant primary progressive aphasia (nfvPPA), a related frontotemporal degeneration. GRN mutations specifically tend to prominent asymmetry, especially with bitemporal asymmetry atrophy and involvement of the insula, parietal lobe, and striatum.
This patient illustrates the relationship of manic behavior, a major manifestation of the bipolar spectrum, and bvFTD. Although strict application of criteria for formal psychiatric disorders can exclude bipolar disorder, 7 the symptoms of mania and bvFTD overlap, and there are a number of reports of manic behavior as an initial manifestation of bvFTD. 2, [8] [9] [10] [11] [12] [13] Studies have shown a relationship of "acquired extroversion" and manic-like euphoria with a right temporal predominant bvFTD, 14, 15 and these patients may have press of speech, tangentiality, derailment, and even clanging and punning.
14 This patient's press of speech and other manic symptoms, are also consistent with the spectrum of behavioral disinhibition, one of the commonest manifestations of bvFTD. 1, 16, 17 Some disinhibited behaviors in bvFTD are highly associated with violations of social tact and personal boundaries, 16, 18 as in this patient. Among patients with bvFTD, investigators report disinhibition associated with decreased volumes in the right amygdala, right ventromedial prefrontal cortex, and right anterior temporal cortex. 19 Patients with manic symptoms and bvFTD highlight the complex relationship between the bipolar spectrum and bvFTD. There appears to be an increased risk of bvFTD and nfvPPA before age 60 in those with BD, with documented cases of patients with a lifelong diagnosis of BD evolving to these frontotemporal degenerations. [20] [21] [22] In these patients, there may be a shared genetic predisposition to both BD and bvFTD, as previously noted from C9orf72 mutations. 23 Investigators have reported C9orf72 mutations in patients with BD preceding bvFTD, with possible genetic expansion from BD to bvFTD. 23 The absence of C9orf72 mutations among a cohort of 206 patients with BD further indicates that this occurrence is rare. 24 Other investigators have reported GRN mutations in patients with late onset BD or with bipolar spectrum disorders preceding the development of bvFTD or nfvPPA. 21, 25 The presence of lower progranulin plasma levels among some patients with BD may also suggest a relationship of GRN mutations with bipolar spectrum disorders. [26] [27] [28] [29] Beyond a common genetic predisposition in some patients, there may be a more common causal relationship of bipolar symptoms with an FTD-like dementia. Among the major psychiatric syndromes, BD is most frequently associated with neurocognitive decline (verbal memory, executive, verbal fluency) and dementia, 30 and both patients with bvFTD and elderly BD patients have deficits in executive functions. 31, 32 The cumulative neurotoxicity of manic and depressive episodes over decades could potentially result in persistent cognitive deterioration during the euthymic phase, frontally predominant cognitive and behavioral changes, and an eventual "bipolar" and non-progressive dementia that mimics bvFTD. 12, 19, 33, 34 This is consistent with four patients with manifestations of BD type I at least 10 years before onset of bvFTD-like symptoms. 35 These four patients had 3-7 years of follow-up without a progressive neurodegenerative course or changes on neuroimaging. 35 The most probable association of bvFTD and manic behavior is a common dysfunction of right frontotemporal neuroanatomical structures involved in emotional behavior. 36, 37 Abnormal volumes and blood flow in frontal and temporal cortical areas are common neuropathological findings in bvFTD that may occur with BD. 38 "Secondary mania" has resulted from strokes and other neurological lesions specifically involving the right inferolateral frontal and right basotemporal regions. [39] [40] [41] Mania may even follow right temporal epileptiform discharges. 42 Moreover, right frontal disease can result in grandiosity, impulsivity, tangentiality with digressions, and free association of ideas to the point of confabulation. [43] [44] [45] Together, these findings suggests that manic behavior originates from right-hemisphere frontotemporal-limbic dysfunction and that, in this case report, this neuroanatomic involvement is more important in producing manic-like behavior than the GRN mutation. 39 In conclusion, the relationship of mania and BD with bvFTD is heterogeneous. Manic symptoms result not only from right frontotemporal disease due to bvFTD and other focal neurological disorders, but also as part of a frontallypredominant cognitive decline in patients with longstanding BD. This last "bipolar dementia" is often mild, non-progressive, and may mimic bvFTD. In some individuals, there also appears to be an association of BD with the frontotemporal degenerations, possibly due to a shared genetic predisposition from mutations in the GRN, C9orf72, or other genes. These are intriguing conclusions, but they are preliminary. We need much more research in order to clearly define the important relationship of bipolar spectrum disorders and bvFTD.
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